355 related articles for article (PubMed ID: 24713029)
1. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.
Ong CW; Elkington PT; Friedland JS
Am J Respir Crit Care Med; 2014 Jul; 190(1):9-18. PubMed ID: 24713029
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.
Walker NF; Clark SO; Oni T; Andreu N; Tezera L; Singh S; Saraiva L; Pedersen B; Kelly DL; Tree JA; D'Armiento JM; Meintjes G; Mauri FA; Williams A; Wilkinson RJ; Friedland JS; Elkington PT
Am J Respir Crit Care Med; 2012 May; 185(9):989-97. PubMed ID: 22345579
[TBL] [Abstract][Full Text] [Related]
3. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis.
Huang Q; Yin Y; Kuai S; Yan Y; Liu J; Zhang Y; Shan Z; Gu L; Pei H; Wang J
Eur J Med Res; 2016 May; 21(1):20. PubMed ID: 27154410
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.
Ong CW; Elkington PT; Brilha S; Ugarte-Gil C; Tome-Esteban MT; Tezera LB; Pabisiak PJ; Moores RC; Sathyamoorthy T; Patel V; Gilman RH; Porter JC; Friedland JS
PLoS Pathog; 2015 May; 11(5):e1004917. PubMed ID: 25996154
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis.
Sabir N; Hussain T; Mangi MH; Zhao D; Zhou X
Cell Prolif; 2019 Jul; 52(4):e12649. PubMed ID: 31199047
[TBL] [Abstract][Full Text] [Related]
6. Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.
Ordonez AA; Tasneen R; Pokkali S; Xu Z; Converse PJ; Klunk MH; Mollura DJ; Nuermberger EL; Jain SK
Dis Model Mech; 2016 Jul; 9(7):779-88. PubMed ID: 27482816
[TBL] [Abstract][Full Text] [Related]
7. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.
Singh S; Kubler A; Singh UK; Singh A; Gardiner H; Prasad R; Elkington PT; Friedland JS
Antimicrob Agents Chemother; 2014 Aug; 58(8):4657-65. PubMed ID: 24890593
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
10. Nanobead-based interventions for the treatment and prevention of tuberculosis.
Griffiths G; Nyström B; Sable SB; Khuller GK
Nat Rev Microbiol; 2010 Nov; 8(11):827-34. PubMed ID: 20938454
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.
Kübler A; Luna B; Larsson C; Ammerman NC; Andrade BB; Orandle M; Bock KW; Xu Z; Bagci U; Mollura DJ; Marshall J; Burns J; Winglee K; Ahidjo BA; Cheung LS; Klunk M; Jain SK; Kumar NP; Babu S; Sher A; Friedland JS; Elkington PT; Bishai WR
J Pathol; 2015 Feb; 235(3):431-44. PubMed ID: 25186281
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.
Tadokera R; Meintjes GA; Wilkinson KA; Skolimowska KH; Walker N; Friedland JS; Maartens G; Elkington PT; Wilkinson RJ
Eur J Immunol; 2014 Jan; 44(1):127-36. PubMed ID: 24136296
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
15. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
Ugarte-Gil CA; Elkington P; Gilman RH; Coronel J; Tezera LB; Bernabe-Ortiz A; Gotuzzo E; Friedland JS; Moore DA
PLoS One; 2013; 8(4):e61333. PubMed ID: 23613834
[TBL] [Abstract][Full Text] [Related]
16. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
Hong MS; Kim Y; Cho EJ; Lee JS; Kwak HK; Kim JH; Kim CT; Cho JS; Park SK; Jeon D; Choi YI; Lee H; Eum SY
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2063-2072. PubMed ID: 28620844
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade.
Rand L; Green JA; Saraiva L; Friedland JS; Elkington PT
J Immunol; 2009 May; 182(9):5865-72. PubMed ID: 19380835
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones and tuberculosis.
Bryskier A; Lowther J
Expert Opin Investig Drugs; 2002 Feb; 11(2):233-58. PubMed ID: 11829714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
